Quantum-Si's third-quarter results reflect ongoing challenges in capital sales, with revenues of $552,000; however, strategic initiatives have led to the acquisition of 12 new customers and significant progress in product innovation.

• Revenue of $552,000, impacted by persistent capital sales headwinds.
• Successfully onboarded 12 new customers, over half from academic labs, following the launch of flexible instrument acquisition options.
• Completed sequencing runs on multiple prototype Proteus systems, marking a key milestone in product development.
• Launched a version 4 sequencing kit in September, enhancing amino acid detection capabilities for customers.
• Active pipeline of publications with five manuscripts submitted, supporting increased scientific validation and market awareness.